Aberdeen Group’s Diversified Healthcare Trust DHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.59M | Sell |
385,889
-47,857
| -11% | -$392K | 0.01% | 722 |
|
|
2026
Q1 | $2.88M | Buy |
433,746
+76,026
| +21% | +$482K | ﹤0.01% | 740 |
|
|
2025
Q4 | $1.73M | Hold |
357,720
| – | – | ﹤0.01% | 795 |
|
|
2025
Q3 | $1.58M | Hold |
357,720
| – | – | ﹤0.01% | 801 |
|
|
2025
Q2 | $1.28M | Hold |
357,720
| – | – | ﹤0.01% | 813 |
|
|
2025
Q1 | $859K | Hold |
357,720
| – | – | ﹤0.01% | 830 |
|
|
2024
Q4 | $823K | Hold |
357,720
| – | – | ﹤0.01% | 837 |
|
|
2024
Q3 | $1.5M | Hold |
357,720
| – | – | ﹤0.01% | 782 |
|
|
2024
Q2 | $1.09M | Hold |
357,720
| – | – | ﹤0.01% | 813 |
|
|
2024
Q1 | $880K | Hold |
357,720
| – | – | ﹤0.01% | 832 |
|
|
2023
Q4 | $1.34M | Buy |
+357,720
| New | +$841K | ﹤0.01% | 811 |
|
|
2022
Q2 | – | Sell |
-52,654
| Closed | -$168K | – | 958 |
|
|
2022
Q1 | $168K | Buy |
52,654
+1,654
| +3% | +$5.05K | ﹤0.01% | 969 |
|
|
2021
Q4 | $158K | Buy |
51,000
+2,033
| +4% | +$6.57K | ﹤0.01% | 1040 |
|
|
2021
Q3 | $166K | Buy |
48,967
+396
| +0.8% | +$1.49K | ﹤0.01% | 1038 |
|
|
2021
Q2 | $203K | Buy |
48,571
+25,495
| +110% | +$105K | ﹤0.01% | 1002 |
|
|
2021
Q1 | $110K | Buy |
23,076
+7,648
| +50% | +$35.2K | ﹤0.01% | 985 |
|
|
2020
Q4 | $64K | Sell |
15,428
-9,894
| -39% | -$39K | ﹤0.01% | 955 |
|
|
2020
Q3 | $89K | Sell |
25,322
-10,689
| -30% | -$41.7K | ﹤0.01% | 929 |
|
|
2020
Q2 | $159K | Sell |
36,011
-12,191
| -25% | -$43.1K | ﹤0.01% | 917 |
|
|
2020
Q1 | $175K | Sell |
48,202
-4,299
| -8% | -$28.2K | ﹤0.01% | 898 |
|
|
2019
Q4 | $443K | Buy |
52,501
+1,238
| +2% | +$10.4K | ﹤0.01% | 891 |
|
|
2019
Q3 | $474K | Buy |
51,263
+5,576
| +12% | +$48.1K | ﹤0.01% | 860 |
|
|
2019
Q2 | $378K | Buy |
45,687
+7,387
| +19% | +$61.5K | ﹤0.01% | 901 |
|
|
2019
Q1 | $451K | Buy |
38,300
+1,084
| +3% | +$13.9K | ﹤0.01% | 867 |
|
|
2018
Q4 | $442K | Buy |
37,216
+3,931
| +12% | +$58.3K | ﹤0.01% | 835 |
|
|
2018
Q3 | $584K | Buy |
33,285
+340
| +1% | +$6.24K | ﹤0.01% | 855 |
|
|
2018
Q2 | $596K | Buy |
32,945
+2,413
| +8% | +$39.9K | ﹤0.01% | 841 |
|
|
2018
Q1 | $478K | Buy |
30,532
+3,530
| +13% | +$58.7K | ﹤0.01% | 766 |
|
|
2017
Q4 | $517K | Buy |
27,002
+7,276
| +37% | +$139K | ﹤0.01% | 764 |
|
|
2017
Q3 | $386K | Buy |
+19,726
| New | +$385K | ﹤0.01% | 768 |
|
Other funds holding DHC
FFL
SPC
H2CM
DKCM
Aberdeen Group's DHC Position: Q2 2026 in Review
Aberdeen Group reduced its Diversified Healthcare Trust (DHC) stake by 11% in Q2 2026, selling an estimated $392K and leaving 385,889 shares worth $3.59M. The position accounts for 0.01% of the portfolio, ranked #722.
Aberdeen Group first reported a position in DHC in Q3 2017 and has held it in 30 quarters since. 240 funds tracked by Wall St. Rank hold DHC as of Q2 2026.
- Aberdeen Group held 385,889 shares of Diversified Healthcare Trust worth $3.59M as of Q2 2026.
- Aberdeen Group sold 47,857 Diversified Healthcare Trust shares in Q2 2026, an estimated $392K.
- Diversified Healthcare Trust made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #722 holding.
- Aberdeen Group first reported a position in Diversified Healthcare Trust in Q3 2017 and has held it in 30 quarters since.
- 240 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.